EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression

Yusuke Kito iD, Kenta Kachi, Michihiro Yoshida iD, Yasuki Hori iD, Akihisa Kato iD, Hidenori Sahashi iD, Tadashi Toyohara, Kayoko Kuno, Akihisa Adachi, Kenji Urakabe, Hiromi Kataoka iD

Molecules · 2024

DOI: 10.3390/molecules29143379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Yusuke Kito und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabolism, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Cell Proliferation, Receptors, Leukotriene, Leukotriene Antagonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholangiocarcinoma (CCA) is a cancer with a poor prognosis due to difficulties in diagnosis and limited treatment options, highlighting the urgent need for new targeted therapies. In a clinical setting, we found that leukotriene levels in bile were higher than in serum. Immunohistochemical analysis of surgically resected samples also revealed that CysLT receptor 1 (CysLTR1) was more highly expressed in CCA than in normal bile duct tissue, prompting us to investigate leukotriene as a potential therapeutic target in CCA. In vitro studies using CCA cell lines expressing CysLTR1 showed that leukotriene D4, a major ligand of CysLTR1, promoted cell proliferation, with increased phosphorylation of AKT and extracellular signal-regulated kinase 1/2 (ERK1/2). Additionally, treatment with two clinically available anti-allergic drugs—zileuton, an inhibitor of CysLT formation, and montelukast, a CysLTR1 inhibitor—had inhibitory effects on cell proliferation and migratory capacity, accompanied by the reduced phosphorylation of AKT and ERK1/2. Furthermore, the simultaneous administration of both drugs synergistically enhanced the inhibitory effect on cell proliferation. Our study suggests that use of these drugs may represent a novel approach to treat CCA through drug repositioning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaCell ProliferationReceptors, LeukotrieneLeukotriene AntagonistsBile Duct NeoplasmsSulfidesQuinolinesHydroxyureaHumansCell Line, TumorAcetatesMaleCyclopropanesCell MovementFemaleMiddle AgedProto-Oncogene Proteins c-aktDisease ProgressionLeukotrienesPhosphorylationAgedLeukotriene D4MAP Kinase Signaling System

Stichwörter der Autor:innen

cholangiocarcinomacysteinyl leukotriene receptor 1drug repositioningleukotriene D4montelukastzileuton

Substanzen

Receptors, Leukotrieneleukotriene D4 receptorLeukotriene AntagonistsSulfidesmontelukastQuinolinesHydroxyureazileutonAcetatesCyclopropanes

Autor:innen und Institutionen

  • Department of Gastroenterology and Metabolism, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.
  • Department of Gastroenterology, Gifu Prefectural Tajimi Hospital, Tajimi 507-8522, Japan.

ORCID-Profile: Yusuke Kito, Michihiro Yoshida, Yasuki Hori, Akihisa Kato, Hidenori Sahashi, Hiromi Kataoka

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kito, Y., Kachi, K., Yoshida, M., Hori, Y., Kato, A., Sahashi, H., Toyohara, T., Kuno, K., Adachi, A., Urakabe, K., & Kataoka, H. (2024). Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression. Molecules. https://doi.org/10.3390/molecules29143379

Vancouver

Kito Y, Kachi K, Yoshida M, Hori Y, Kato A, Sahashi H, et al. Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression. Molecules. 2024. doi:10.3390/molecules29143379

BibTeX
@article{Kito2024,
  author = {Kito, Yusuke and Kachi, Kenta and Yoshida, Michihiro and Hori, Yasuki and Kato, Akihisa and Sahashi, Hidenori and Toyohara, Tadashi and Kuno, Kayoko and Adachi, Akihisa and Urakabe, Kenji and Kataoka, Hiromi},
  title = {Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29143379}
}
Kostenlos starten →